The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth
Article in The Journal of Infectious Diseases (September 2023)
The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.
Overcoming Mycobacterium tuberculosis Drug Resistance: Novel Medications and Repositioning Strategies
Article in ACS Omega (September 2023)
The challenge of post-tuberculosis lung disease
Book chapter (September 2023)